eMIMS New Product
Ciproxin licensed for UTI in children
23-Jun-08
The licence for Ciproxin (ciprofloxacin) has been extended to include the second- and third-line
treatment of complicated UTIs and pyelonephritis in children and adolescents aged between 1-17 years.
The dose is 10-20mg/kg orally every 12 hours up to a maximum of 750mg per dose. The recommended duration of treatment is 10-21 days.
Further information: Bayer plc 01635 563000
Tools
Related Articles
Related Fact Sheets
Related Drugs By Area
Related Clinical Ask the Expert
Latest Guidelines
GMS Contract Action Plan
Jobs
Job of the Week
- Practice Manager South West England
- Part-time Practice Manager Central London
- Business Manager South East England
Comments
Only registered users may comment. Log in now or register for a free account.